Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: A potent prognostic factor

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Verma, Mohit K ^a,d   Miki, Yasuhiro ^a,b   Abe, Keiko ^a   Suzuki, Takashi ^a,b   Niikawa, Hiromichi ^b   Suzuki, Satoshi ^c   Kondo, Takashi ^b   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c JAPANESE RED CROSS SOCIETY   (Japan)

^d JACKSON LABORATORY   (United States)

Author keywords

17 hydroxysteroid dehydrogenase; Intratumoral estrogens; Lung cancer; Targeted therapy

Indexed keywords

AROMATASE; AROMATASE INHIBITOR; ENZYME ANTIBODY; ESTRADIOL; ESTRONE; SMALL INTERFERING RNA; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE 1; TESTOSTERONE 17BETA DEHYDROGENASE 2; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CELL PROLIFERATION; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; FEMALE; GENE SILENCING; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOLOGY; PROTEIN FUNCTION; PROTEIN TARGETING; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

17-HYDROXYSTEROID DEHYDROGENASES; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; ESTRADIOL; ESTRONE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TREATMENT OUTCOME;

EID: 84880016670     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-167     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E. Cancer statistics. CA Cancer J Clin 2008, 58:71-96.
2. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006, 98:691-699.
3. Hershberger PA, Vasquez AC, Kanterewicz B, Land S, Siegfried JM, Nichols M. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 2005, 65:1598-1605.
4. Verma MK, Miki Y, Sasano H. Sex steroid receptors in human lung diseases. J Steroid Biochem Mol Biol 2011, 127:216-222.
5. Hershberger PA, Stabile LP, Kanterewicz B, Rothstein ME, Gubish CT, Land S, Shuai Y, Siegfried JM, Nichols M. Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. J Steroid Biochem Mol Biol 2009, 116:102-109.
6. Ross H, Oldham FB, Bandstra B, Sandalic L, Bianco J, Bonomi P, Singer JW. Serum-free estradiol (E2) levels are prognostic in men with chemotherapy-naïve advanced non-small cell lung cancer and performance status (PS) 2 [abstract]. J Clin Oncol (Meeting Abstr) 2007, 25:7683-7683.
7. Verma MK, Miki Y, Sasano H. Aromatase in human lung carcinoma. Steroids 2011, 76:759-764.
8. Weinberg OK, Marquez-Garban DC, Fishbein MC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, Pietras RJ. Aromatase inhibitors in human lung cancer therapy. Cancer Res 2005, 65:11287-11291.
9. ClinicalTrial.gov Identifier; NCT00932152: University of Pittsburgh, PA, USA Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer 2009, Available from: July 1, 2009 at http://clinicaltrials.gov/ct2/show/record/NCT00932152, ClinicalTrial.gov Identifier; NCT00932152: University of Pittsburgh, PA, USA.
10. Nagasaki S, Miki Y, Akahira J, Suzuki T, Sasano H. 17beta-hydroxysteroid dehydrogenases in human breast cancer. Ann N Y Acad Sci 2009, 1155:25-32.
11. Oster A, Hinsberger S, Werth R, Marchais-Oberwinkler S, Frotscher M, Hartmann RW. Bicyclic substituted hydroxyphenylmethanones as novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases. J Med Chem 2010, 53:8176-8186.
12. Marchais-Oberwinkler S, Wetzel M, Ziegler E, Kruchten P, Werth R, Henn C, Hartmann RW, Frotscher M. New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases. J Med Chem 2011, 54:534-547.
13. Starčević S, Kocbek P, Hribar G, Rižner TL, Gobec S. Biochemical and biological evaluation of novel potent coumarin inhibitor of 17β-HSD type 1. Chem Biol Interact 2011, 191:60-65.
14. Sasano H, Anderson TJ, Silverberg SG, Santen RJ, Conway M, Edwards DP, Krause A, Bhatnagar AS, Evans DB, Miller WR. The validation of new aromatase monoclonal antibodies for immunohistochemistry-a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol 2005, 95:35-39.
15. Skov BG, Fischer BM, Pappot H. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer 2008, 59:88-94.
16. Ishibashi H, Suzuki T, Suzuki S, Niikawa H, Lu L, Miki Y, Moriya T, Hayashi S, Handa M, Kondo T, Sasano H. Progesterone receptor in non-small cell lung cancer-a potent prognostic factor and possible target for endocrine therapy. Cancer Res 2005, 65:6450-6458.
17. Suzuki T, Miki Y, Moriya T, Niikawa H, Lu L, Miki Y, Moriya T, Hayashi S, Handa M, Kondo T, Sasano H. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer 2007, 120:285-891.
18. Poutanen M, Isomaa V, Lehto VP, Vihko R. Immunohistochemical analysis of 17-β hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer 1992, 50:386-390.
19. Niikawa H, Suzuki T, Suzuki S, Nagasaki S, Akahira J, Honma S, Evans DB, Hayashi S, Kondo T, Sasano H. Intratumoral Estrogens and Estrogen receptors in Non-small cell lung carcinoma. Clin Cancer Res 2008, 14:4417-4426.
20. Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, Moriya T, Hirakawa H, Evans DB, Hayashi S, Ohuchi N, Sasano H. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Cancer Res 2007, 67:3945-354.
21. Verma MK, Miki Y, Abe K, Niikawa H, Sasano H. Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma. Expert Opinion Therapeutic Targets 2012, 16:S91-S102.
22. Aka JA, Mazumdar M, Chen CQ, Poirier D, Lin SX. 17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production. Mol Endocrinol 2010, 24:832-845.
23. Song RX, Santen RJ. Apoptotic action of estrogen. Apoptosis 2003, 8:55-60.
24. Yue W, Wang JP, Li Y, Fan P, Liu G, Zhang N, Conaway M, Wang H, Korach KS, Bocchinfuso W. Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. Int J Cancer 2010, 127:1748-1757.
25. Verma MK, Miki Y, Abe K, Niikawa H, Nagasaki S, Suzuki S, Kondo T, Sasano H. Estrogen receptor beta and aromatase in lung carcinoma patients: gender dependent clinical outcome. Life Sciences 2012, 91:800-808.
26. Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 2005, 65:1459-70.
27. Chanplakorn N, Chanplakorn P, Suzuki T, Ono K, Chan MS, Miki Y, Saji S, Ueno T, Toi M, Sasano H. Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients. Breast Cancer Res Treat 2010, 120:639-648.
28. Rotinen M, Villar J, Encío I. Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage. J Physiol Biochem 2012, 68:461-473.